Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IS
$ 11.73
-2.82 %
$ 3.54 B
Market Cap
-4.55
P/E
BALANCE SHEET
950 M
ASSETS
1.88 B
LIABILITIES
-932 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Alvotech
| Current Assets | 195 M |
| Cash & Short-Term Investments | 11.2 M |
| Receivables | 87.2 M |
| Other Current Assets | 96.5 M |
| Non-Current Assets | 755 M |
| Long-Term Investments | 18.5 M |
| PP&E | 357 M |
| Other Non-Current Assets | 380 M |
| Current Liabilities | 261 M |
| Accounts Payable | 80.6 M |
| Short-Term Debt | 47.7 M |
| Other Current Liabilities | 133 M |
| Non-Current Liabilities | 1.62 B |
| Long-Term Debt | 1.03 B |
| Other Non-Current Liabilities | 594 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | ||
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 11.2 | 66.4 | 17.6 | 31.7 | |
| Short Term Investments | 0 | 0 | 0 | 0 | |
| Receivables | 87.2 | 71.4 | 53.9 | 38.9 | |
| Inventory | 74.4 | 71.5 | 39.1 | 9.6 | |
| Other Current Assets | 22.0 | 21.5 | 9.3 | 5.9 | |
| Total Current Assets | 194.8 | 230.7 | 119.8 | 86.2 | |
| PP&E | 356.6 | 268.1 | 205.3 | 177.0 | |
| Intangible Assets | 19.1 | 25.7 | 21.5 | 6.3 | |
| Goodwill | 12.1 | 11.6 | 12.4 | 13.4 | |
| Long Term Investments | 18.5 | 48.6 | 55.3 | 56.7 | |
| Other Long Term Assets | 39.2 | 34.3 | 13.2 | 13.0 | |
| Other Assets | 0 | 0 | 0 | 0 | |
| Total Assets | 950.1 | 828.4 | 598.0 | 474.4 | |
| LIABILITIES | |||||
| Accounts Payable | 80.6 | 49.2 | 28.6 | 12.0 | |
| Short Term Debt | 47.7 | 25.1 | 10.1 | 8.0 | |
| Other Current Liabilities | 72.6 | 55.2 | 35.1 | 16.8 | |
| Total Current Liabilities | 260.9 | 167.3 | 111.8 | 51.0 | |
| Long Term Debt | 1 027.8 | 780.0 | 513.0 | 668.9 | |
| Deferred Tax Income | 53 K | 0.3 | 0.1 | 0.2 | |
| Other Liabilities | 520.6 | 388.2 | 108.8 | 621.8 | |
| Total Liabilities | 1 882.6 | 1 392.9 | 733.6 | 1 341.7 | |
| EQUITY | |||||
| Common Stock | 2.3 | 2.1 | 0.1 | 73 K | |
| Retained Earnings | (2 205.8) | (1 654.1) | (1 140.5) | (1 039.0) | |
| Other Accumulative Comprehensive Income/Loss | 41.4 | 29.1 | 4.7 | 5.0 | |
| Total Equity | (932.5) | (564.4) | (135.6) | (867.2) | |
| Total Liabilities and Equity | 950.1 | 828.4 | 598.0 | 474.4 | |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 227.3 | 197.7 | 31.2 | 31.2 | 243.6 |